Zogenix Completes Enrollment in First ZX008 Phase 3 Clinical Trial in Dravet Syndrome
Apr 27, 2017 12:03 pm UTC| Business
EMERYVILLE, Calif., April 27, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that the last...
Apr 27, 2017 12:03 pm UTC| Business
HORSHAM, Pa., April 27, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of...
Apr 27, 2017 12:03 pm UTC| Business
HORSHAM, Pa., April 27, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of...
BASF: Sales and earnings considerably above prior first quarter
Apr 27, 2017 12:03 pm UTC| Business
Sales of €16.9billion (up 19%)Positive volume trend continues (up 8%)EBIT before special items of €2.5billion (up 29%), of which €2.0billion generated by chemicals businessOutlook for 2017 confirmed LUDWIGSHAFEN, Germany...
BASF: Sales and earnings considerably above prior first quarter
Apr 27, 2017 12:03 pm UTC| Business
Sales of €16.9billion (up 19%)Positive volume trend continues (up 8%)EBIT before special items of €2.5billion (up 29%), of which €2.0billion generated by chemicals businessOutlook for 2017 confirmed LUDWIGSHAFEN, Germany...
BASF: Sales and earnings considerably above prior first quarter
Apr 27, 2017 12:03 pm UTC| Business
Sales of €16.9billion (up 19%)Positive volume trend continues (up 8%)EBIT before special items of €2.5billion (up 29%), of which €2.0billion generated by chemicals businessOutlook for 2017 confirmed LUDWIGSHAFEN, Germany...
Franklin Electric Reports First Quarter 2017 Sales and Earnings
Apr 27, 2017 12:03 pm UTC| Business
FORT WAYNE, Ind., April 27, 2017 -- Franklin Electric Co., Inc. (NASDAQ:FELE) reported first quarter 2017 GAAP fully diluted earnings per share (EPS) of $0.33, versus a GAAP fully diluted EPS in the first quarter 2016...